GENEVA, Nov. 5 -- ERASCA, INC. (3115 Merryfield Row, Suite 300San Diego, California 92121) filed a patent application (PCT/US2025/025994) for "SHP2 AND EGFR INHIBITORS FOR THE TREATMENT OF CHORDOMA" on Apr 23, 2025. With publication no. WO/2025/226830, the details related to the patent application was published on Oct 30, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): BRAIL, Leslie Harris (3115 Merryfield Row, Suite 300San Diego, California 92121), GOUNDER, Mrinal M. (1275 York Avenue, Box 524New York, New York 10065), ROSEN, Ezra Y. (1275 York Avenue, Box 524New York, New York 10065)
Abst...